Searched for
AFLIBERCEPT BIOSIMILAR INDIA
Zydus Lifesciences in focus after USFDA clears Ahmedabad plant, Aflibercept biosimilar launchZydus Lifesciences is in focus after receiving USFDA clearance with zero observations for its Ahmedabad facility and launching ANYRA, India...- Zydus launches biosimilar for ophthalmic careZydus Lifesciences has introduced Anyra, its first indigenously developed biosimilar for the treatment of visual impairment in India. This ...
- Stocks in news: Wipro, Dr Reddy's, Tata Steel, Tejas Networks, SAILIndian markets saw a rebound on Friday, driven by positive global sentiment. Key companies like Wipro, Dr Reddy's, Tata Steel, and SAIL are...
- Biocon plans ₹4,500-cr QIP to raise stake in Biologics unit: Kiran ShawBiocon is planning a ₹4,500 crore fundraise to increase promoter stake in Biocon Biologics and convert structured venture debt into equity,...
- How is India transforming the global biopharma landscape?In 2024, India's biopharma sector marked notable achievements, with approvals of key biosimilars and the launch of advanced CAR-T therapy. ...
- Biocon Biologics to raise debt of Rs 4,500 crore for Viatris PayoutBiocon Biologics plans to raise ₹4,500 crore with HSBC and MUFG's aid for a $175 million Aflibercept option. Previous funding by Kotak and ...
- 12 stocks that are BofA Securities' top buys from 7 sectors. Do you own them?While BofA remained overweight on select domestic cyclicals such as industrials, financials and automobile stocks, it has marginally trimme...
- Shilpa Medicare arm gets NoC to conduct clinical studies for its Biosimilar AfliberceptListed pharmaceutical entity Shilpa Medicare on Monday informed the exchanges that its subsidiary Shilpa Biologicals (SBPL) has received a ...
- Viatris deal pinches Biocon, but may prove a good betThe $3.3-billion acquisition - that includes $2.3 billion cash and a 12.9% equity stake in BBL - stands at over half of the market cap of B...
- Biocon Biologics acquires Viatris' biosimilar business for $3.34 billionBBL said the cash payment of $2 billion to be funded by $800 million raised through equity infusion in BBL and the remainder to be funded b...
Load More
